Lights and shadows of the microcoaxial pump device in a unique setting: cardiogenic shock due to acute myocardial infarction in patient with unknown hypertrophic cardiomyopathy
Anno:
2023
Cardiogenic shock remains the leading cause of death in patients with acute myocardial infarction (AMICS). The IntraAortic Balloon Pump (IABP) has been the device of first choice for these patients for years, but it has not shown a mortality benefit over optimal medical therapy. The Impella (AbioMed, Danvers, Massachusetts) is…